Sign in
4

Changes in Ownership

ARS Pharmaceuticals, Inc. Filed Acc 0001548538-20-000027

10% owner bought 47,619 shares at $21.00 ($999,999)

  • 10% owner acquired 2,174,179 shares (conversion)

From the SEC's structured data for this filing

Trades in this filing

Presidio Management Group XII, L.L.C. · 10% owner

Table I: Non-derivative

5 lines
Date Transaction Shares Price Value Owned after D/I
2020-12-08 Conversion : show line 1 in the form +1,779,969 1,779,969 I
2020-12-08 Conversion : show line 2 in the form +289,198 2,069,167 I
2020-12-08 Conversion : show line 3 in the form +90,335 90,335 I
2020-12-08 Conversion : show line 4 in the form +14,677 105,012 I
2020-12-08 Purchase : show line 5 in the form +47,619 $21.00 $999,999 47,619 I
Open-market purchases · 47,619 sh · avg $21.00 · $999,999

Table II: Derivative

4 lines
Date Transaction Shares Underlying Owned after D/I
2020-12-08 Conversion : show line 6 in the form Preferred Series B Stock −6,609,027 1,779,969 0 I
2020-12-08 Conversion : show line 7 in the form Preferred Series B Stock −335,417 90,335 0 I
2020-12-08 Conversion : show line 8 in the form Preferred Series C Stock −1,073,793 289,198 0 I
2020-12-08 Conversion : show line 9 in the form Preferred Series C Stock −54,496 14,677 0 I
Loading xslF345X03/edgar.xml…